Rita Jain, M.D.

Former Executive Vice President and Chief Medical Officer of ChemoCentryx

Rita Jain, M.D., joined our Board of Directors in April 2023. Dr. Jain is a rheumatologist and currently serves on the Board of Directors of Provention Bio, Inc. and Celldex Therapeutics, and serves on the supervisory board of AM Pharma. She previously served on the Board of Directors of ChemoCentryx, Inc. until its acquisition by Amgen. Dr. Jain has served as executive vice president and chief medical officer of ChemoCentryx, Inc., chief medical officer of Immunovant, Inc. and prior to that, senior vice president and chief medical officer of Akebia Therapeutics, Inc. Before joining Akebia, Dr. Jain was vice president of Men’s and Women’s Health and Metabolic Development at AbbVie, Inc. and served in various leadership roles at Abbott Laboratories, including divisional vice president. Prior to her time at Abbott, she held management positions in the Arthritis, Inflammation and Pain Group at G.D. Searle, which was acquired by Pharmacia and, later, Pfizer. She was responsible for leading the design and execution of multiple late-stage programs, including for Orilissa┬« and Oriahnn┬« and has also led programs across a diverse set of therapeutic areas, including immunology, inflammation, pain and nephrology. Earlier in her career, Dr. Jain served as a faculty member at North Shore University Hospital in New York.